• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Glaukos Corp (NY: GKOS )

    119.30 -0.39 (-0.33%)
    Streaming Delayed Price Updated: 10:38 AM EDT, Jul 30, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Glaukos Corp

    < Previous 1 2 3 4 5 6 7 Next >
    10 Analysts Have This To Say About Glaukos
    Via Benzinga
    This Visa Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday
    Via Benzinga
    Glaukos to Release Second Quarter 2024 Financial Results after Market Close on July 31
    From Glaukos Corporation
    Via Business Wire
    Glaukos Announces Agreements to Exchange $230 Million in Principal Amount of Its 2.75% Convertible Senior Notes Due 2027 for Common Stock
    From Glaukos Corporation
    Via Business Wire
    Deep Dive Into Glaukos Stock: Analyst Perspectives (12 Ratings)
    Via Benzinga
    Analyst Ratings For Glaukos
    Via Benzinga
    5 Analysts Have This To Say About Glaukos
    Via Benzinga
    Glaukos Announces Participation in Upcoming Investor Conferences
    From Glaukos Corporation
    Via Business Wire
    Eye Disease-Focused Glaukos' 'Investor Interest Should Continue To Gain Momentum:' Analyst
    Glaukos reports Q1 adjusted EPS loss, sales beat estimates. Strong guidance for 2024 with positive analyst sentiment, driving stock up 6.22%. 
    Via Benzinga
    Topics Earnings
    Exposures Financial
    C.H. Robinson Worldwide Posts Upbeat Results, Joins Avis Budget Group, Qualcomm, BorgWarner, Moderna And Other Big Stocks Moving Higher On Thursday
    Via Benzinga
    Glaukos: Q4 Earnings Insights
    Via Benzinga
    Earnings Scheduled For February 21, 2024
    Companies Reporting Before The Bell • Gatos Silver (NYSE:GATO) is estimated to report quarterly earnings at $0.09 per share on revenue of $83.00 million. 
    Via Benzinga
    Analyst Ratings For Glaukos
    Via Benzinga
    Unveiling 7 Analyst Insights On Glaukos
    Via Benzinga
    GKOS Stock Earnings: Glaukos Misses EPS, Beats Revenue for Q1 2024
    GKOS stock results show that Glaukos missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024. 
    Via InvestorPlace
    Glaukos Announces First Quarter 2024 Financial Results
    From Glaukos Corporation
    Via Business Wire
    Glaukos Announces the Release of its 2023 Sustainability Report
    From Glaukos Corporation
    Via Business Wire
    Glaukos to Release First Quarter 2024 Financial Results after Market Close on May 1
    From Glaukos Corporation
    Via Business Wire
    Signet Jewelers, Dave & Buster's Entertainment, Blue Owl Capital And Other Big Stocks Moving Higher On Wednesday
    U.S. stocks were higher, with the Dow Jones gaining over 50 points on Wednesday. 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Glaukos Receives Permanent J-code for iDose® TR (travoprost intracameral implant)
    From Glaukos Corporation
    Via Business Wire
    Glaukos To Present Numerous Scientific Abstracts at the 2024 American Society of Cataract and Refractive Surgery Annual Meeting
    From Glaukos Corporation
    Via Business Wire
    Analog Devices To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Thursday
    Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. 
    Via Benzinga
    Glaukos Announces Fourth Quarter and Full Year 2023 Financial Results
    From Glaukos Corporation
    Via Business Wire
    Glaukos to Release Fourth Quarter and Full Year 2023 Financial Results after Market Close on February 21
    From Glaukos Corporation
    Via Business Wire
    Glaukos Announces Preliminary, Unaudited Fourth Quarter and Full Year 2023 Net Sales and Reaffirms 2024 Revenue Guidance
    From Glaukos Corporation
    Via Business Wire
    Glaukos' Newly Approved Glaucoma Treatment Is The 'Biggest Driver To Watch': Analyst
    Shares of Glaukos Corp (NYSE: GKOS) continued to climb in early trading on Thursday, after the company’s iDose TR (travoprost intracameral implant) received U.S. 
    Via Benzinga
    Amazon.com To Rally Over 38%? Here Are 10 Top Analyst Forecasts For Thursday
    Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. 
    Via Benzinga
    Glaukos Announces Participation in the J.P. Morgan Healthcare Conference
    From Glaukos Corporation
    Via Business Wire
    iDoseTR Approval Sets Stage for Glaukos' Game-Changing Product, Surpassing Market Expectations, Says Analyst
    Thursday, the FDA approved Glaukos Corporation's (NYSE: GKOS) marketing application for a single administration per eye of iDose TR (travoprost intracameral implant) 75 mcg, a prostaglandin analog... 
    Via Benzinga
    Exposures Product Safety
    Dow Extends Rally As Treasury Yields Tank
    The Dow Jones Industrial Average is charging full speed ahead, up 78 points this afternoon after yesterday closing at record highs, on the heels of the Federal Reserve's rate decision. 
    Via Talk Markets
    Topics Economy Stocks
    Exposures Interest Rates US Equities
    < Previous 1 2 3 4 5 6 7 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.